Kavitha Bhat Schelbert

Kavitha Bhat Schelbert practices at Renaissance Family Practice-UPMC, Inc in Verona, Pennsylvania.

Kavitha Bhat Schelbert's NPI, 1912993502, was assigned on September 20, 2005. Kavitha Bhat Schelbert graduated from Northwestern University Feinberg Medical School in 1994. Kavitha Bhat Schelbert holds Pennsylvania license MD435235.

Kavitha Bhat Schelbert's primary practice is Renaissance Family Practice-UPMC, Inc, at 5769 Saltsburg Rd, Verona, PA 15147 in Allegheny County. The practice phone is (412) 793-8870.

Kavitha Bhat Schelbert's primary practice is Renaissance Family Practice-UPMC, Inc in Verona, Pennsylvania. Kavitha Bhat Schelbert is also affiliated with UPMC Presbyterian. The medical group on file is Stull, Jarvis, and Spinola Internal Medicine Associates-UPMC. Dmand AI also links Kavitha Bhat Schelbert to 2 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kavitha Bhat Schelbert practices, 6 sites in all. Vendor and product names are available with a free account.

Family medicine is Kavitha Bhat Schelbert's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Kavitha Bhat Schelbert is licensed in Pennsylvania.

CMS data shows 295 Medicare services from Kavitha Bhat Schelbert across 6 procedure codes in 2024, for 99 Medicare patients. Medicare paid $15,571 for them. Every service was in an office.

CMS counts 99 Medicare patients who saw Kavitha Bhat Schelbert in 2024. The largest group is 65 to 74, with 62 patients. 53% of them have high blood pressure, and 49% have high cholesterol. 12% are also on Medicaid. Their average risk score is 0.97, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Kavitha Bhat Schelbert's median patient age at 61, with 77% women.

In 2024, Kavitha Bhat Schelbert wrote 5,295 Medicare Part D claims for 401 patients. 88% of them were for generic drugs. CMS names the drug for 4,581 of them, across 107 drugs with 11 or more claims each, at $308,709 in total drug cost. In 2023, CMS named 4,325 claims across 104 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Kavitha Bhat Schelbert for performance year 2024, reported as part of a group. Kavitha Bhat Schelbert accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Kavitha Bhat Schelbert as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 1 general payment to Kavitha Bhat Schelbert from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Exact Sciences Corporation paid the most, $21.

Kavitha Bhat Schelbert graduated from Northwestern University Feinberg Medical School in 1994.